Category: Cannabis Stocks
Cannabis Was Ready For Wall St., But Was Wall St. Ready For Cannabis?
Trulieve and Glass House’s NYSE uplistings mark a milestone, but experts warn of investor education gaps, geographic complexity, and a…
Is Jazz still the best cannabis stock after federal rescheduling?
Jazz Pharmaceuticals JAZZ is best known for its market-leading oxybate franchise, but the company has also carved out a unique…
Tilray Brands (NASDAQ:TLRY) Deepens Its Medical Cannabis Reach
Tilray Brands advances international medical cannabis access while regulatory progress, beverages, wellness brands, and operational discipline shape its evolving business…
Should you buy Tilray Brands stock before July 28?
Tilray will release its year-end numbers next week, which could have a significant impact on the stock.
ACB stock down 28% in three months: Time to buy the dip or cash out?
Shares of Aurora Cannabis ACB have lost 27% over the past three months, despite the cannabis operator delivering better-than-expected fourth-quarter…
Why Is Aurora Cannabis (NASDAQ:ACB) Back In Focus?
Aurora Cannabis gains attention after fresh recognition highlights its medical cannabis operations, product quality, compliance, and global reach.
MSOS: Adult-Use Rescheduling The Next Catalyst For Cannabis Stocks
The AdvisorShares Pure US Cannabis ETF is rated a buy, driven by real regulatory progress and potential further catalysts. Click…
Why Is Trulieve Cannabis (NYSE:TRLV) Watching NYSE Composite?
Explore Trulieve Cannabis (NYSE:TRLV), operating across regulated cannabis markets, with insights into business operations, Florida presence, and the company’s role…
Is Canopy Growth stock finally worth buying after losing 99% of its value?
A lower stock price doesn’t eliminate investment risk.
Tilray’s stock is down over 50% this year. Has it become a bargain buy?
The cannabis stock recently hit a new 52-week low.
Recent Comments